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ABSTRACT
Objective: Comparing in human semen samples with low initial quality, the effects of 2
techniques of cryopreservation and dilution/centrifugation after thawing on the spermatic motility
and vitality.
Materials and Methods: Semen samples from 15 oligo and/or asthenozoospermic individuals
assisted in the infertility sector of a tertiary hospital were obtained through masturbation. The samples
were divided into 2 portions of equal volume, and diluted (1:1; v/v) with the cryoprotector containing
glycerol (Test yolk buffer). One portion was frozen through the technique of liquid nitrogen vapor
with static phases (group I - GI), while the other was frozen through a programmable biological
freezer with linear speed (Planer, Kryo 10, series III) (group II - GII). The following parameters
were assessed before freezing and after thawing: percentage of spermatozoa with progressive motility
(Prog%) and percentage of live spermatozoa (Vit%). After defrosting, Prog% was assessed before
and after removal of cryoprotector diluent, in different time intervals (zero, 3 h, and 24 h). The
statistical analysis has been accomplished by using the non-parametric tests of Wilcoxon and Friedman.
Results: There was significant reduction of Prog% and Vit% from before freezing to after
defrosting in both groups, I and II (p < 0.001). Values of Prog% and Vit% were not statistically
different between groups, after thawing. It has been observed a significant reduction in Prog% among
portions frozen with the automated technique after dilution and centrifugation for removal of
cryoprotector (p = 0.006). After cryoprotector removal, Prog% has been kept unaltered, in both
groups, during the first 3 hours of incubation, although being superior in group I (p = 0,04). There
was a significant decrease in Prog% after 24 hours of incubation, in both groups (p < 0,01).
Conclusion: For human semen samples with low initial quality, freezing through vapor technique
or through the automated technique showed to be equivalent in regarding recovery of live spermatozoa
with progressive motility. The effects of dilution and centrifugation to remove the cryoprotector had a
negative impact only in samples frozen through the automated technique. In both techniques, progressive
motility is kept constant during the  first 3 hours after  thawing and removal of the cryoprotector, but is
drastically diminished by the end of an incubation period of 24 hours.
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INTRODUCTION
Cryopreservation of human semen is used to
preserve the individual’s fertility in several situations,
such as before surgical procedures that can harm fer-
tility, before vasectomies, or before chemotherapeu-
tic and radiotherapeutic treatments for specific can-
cer cases, which generally cause germinal aplasia (1).
Besides that, semen banks are used to supply donor
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semen to infertile couples (2). In artificial insemina-
tions with donor semen, the use of cryopreserved se-
men is mandatory, and it should be kept under quar-
antine for at least 6 months, in order to avoid the pres-
ence of acquired immunodeficiency syndrome, among
other sexually transmitted diseases (3). More recently,
cryopreservation is been employed to store exceed-
ing spermatozoa, aspirated from the epididymis or
the testicle, for eventual use in procedures of high
complexity assisted reproduction (example: ICSI –
intracytoplasmic sperm injection), and to store sper-
matozoa obtained during reconstructive microsurger-
ies of male genital tract (vasovasostomy and
vasoepididymostomy), as additional fertility guaran-
tees (4).
Nevertheless, even with the use of advanced
cryopreservation techniques, 25 to 75% of spermato-
zoa die or are irreversibly harmed during the process
(5). Thus, researches aiming to improve the final qual-
ity of cryopreserved human semen are welcome, for
they can benefit a greater number of patients through
the increase of pregnancy indexes. The objective of
this study was to evaluate, in human semen samples
with low initial quality, the effects of 2
cryopreservation techniques on the spermatic motil-
ity and vitality, as well as the impact of dilution/cen-
trifugation after thawing.
MATERIALS AND METHODS
Samples Collection and Seminal Analysis
Semen samples of individuals assisted in the
human reproduction sector of a university hospital
were obtained through masturbation in sterile con-
tainers after sexual abstinence of 48 to 72 hours. The
ethics committee for research in the institution has
approved the study, and all participants signed free
and informed consent. Each ejaculate sample was
incubated for 30 minutes at 37°C to allow liquefac-
tion. Samples were analyzed in accordance with the
criteria established by OMS (6). The percentage of
spermatozoa showing progressive motility [degrees
a + b, being classified as (a), the spermatozoon with
fast progressive linear movement, and as (b), slow
progressive linear movement, or non-linear - Prog%],
the percentage of live spermatozoa (Vit%), and the
number of polymorphonuclear leukocytes has been
evaluated. Sperm vitality has been evaluated through
the eosin-negrosin supravital technique, and the num-
ber of leukocytes through the myeloperoxidase tech-
nique. The criteria for inclusion of samples in the
present study were: ejaculated volume greater or equal
to 2.0 mL, sperm concentration < 20x106/mL, pro-
gressive sperm motility < 50%, and number of poly-
morphonuclear leukocytes < 1.0x106/mL. At least 200
spermatozoa were analyzed from each specimen, for
calculation of Prog% and Vit%.
Cryopreservation Technique
Each individual supplied a single sample of
semen that has been divided in 2 parts of equal vol-
ume. As cryoprotective agent, a ready to use diluent
has been used, commercially available, containing egg
yoke at 20% (v/v), glycerol at 12% (v/v), 85 mM of
Tris ([hydroximethyl]amino methane), 189 mM TES
(n-Tris [hydroximethyl] methyl-2-amino-ethane-
sulphonic acid), 11 mM of glucose, 0,25 mg/mL of
streptomycin sulfate, 0.15 mg/mL of penicillin pH =
7,35 (Test yolk-buffer, Irvine Scientific, Santa Ana,
USA). The containers containing the cryoprotective
diluent were kept stored at -20ºC, and were defrosted
in water bath at 37ºC, for 20 minutes, before use. In a
15 mL polystyrene tube (Falcon, San Diego, USA),
portions of the cryoprotector media, corresponding
to 25% of volume of semen to be frozen, were added
to each part at each 5 minutes, and mixed by using
the aliquot mixer (Miles, Elkhart, USA). This proce-
dure has been repeated until obtaining equal volume
of diluent media and ejaculated part (proportion 1:1).
The final mix was distributed into plastic sterile tubes,
cylindrical with conic base, each one capable of han-
dling 1.0 mL of mix (Corning, USA).
One of the parts was cryopreserved by using
the liquid nitrogen vapor technique with static phases
(group I - GI), while the other was frozen by using a
biologic freezer with programmable linear velocities
(Planer, Kryo 10, series III) (group II - GII). With the
vapor technique freezing, the tubes were arranged in
metallic stands appropriate to be used with nitrogen
drum. A maximum of 2 tubes were arranged in each
stand. Real freezing consisted of 3 consecutive steps:
a) cooling phase: the metallic stands containing the
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cylindrical tubes with the sample were placed inside
a freezer, with temperature adjusted to 20ºC negative
in horizontal position, and maintained inside this en-
vironment for 8 minutes, in order to reach the tem-
perature of +4°C; b) freezing phase: the metallic
stands containing the cylindrical tubes were trans-
ferred to the mug of the liquid nitrogen drum (N2L),
being each stand placed in the vertical position, with
the 2 cylindrical tubes situated in upper positions.
Then, the mug was transferred to the drum contain-
ing liquid nitrogen just in its base, so that the inferior
cylindrical tube was placed at 15 cm of the N2L level,
and the upper tube at 18 cm. Temperature in the re-
gion occupied by the cylindrical tubes was kept
around -79ºC, checked through appropriate thermom-
eter (Fisher, USA), and the tubes were kept inside
this closed N2L vapor environment for a 2 hours pe-
riod. Freezing speed of this phase is estimated in 10°C/
minute. Checking of N2L level was accomplished in
a systematic way before the beginning of
cryopreservation process; c) storage phase: after 2
hours under N2L vapor, the metallic stands contain-
ing the cylindrical tubes were transferred to the stor-
age drum, being then immersed in N2L at -196ºC.
Automated freezing was accomplished by
using a biologic freezer (Planer Kryo 10, series III,
Perkasie, Pennsylvania, USA), programmed for lin-
ear reduction of temperature, in accordance with the
following protocol: a) 0.5°C/minute, from room tem-
perature up to –6,0°C; b) 10°C/minute, from –6°C up
to –86°C; c) immersion in liquid nitrogen at –196°C.
Both parts remained stored in liquid nitro-
gen for at least 48 hours. For sample thawing, cylin-
drical tubes were removed from the storage drum and
kept at room temperature for 5 minutes. Next, they
were transferred to a greenhouse at 37ºC, where they
stayed for another 20 minutes. Removal of cryopro-
tective diluent was accomplished through the dilu-
tion of the thawed specimen by using modified BWW
medium (HEPES-Biggers-Whitten-Whittingam,
Irvine Scientific, Santa Ana, CA) (1:2, v/v), enriched
with 5% of human albumin, and centrifuged for 5
minutes at 1000 rpm. The same procedure was re-
peated to completely remove the diluent, and the re-
sulting sediment was re-suspended in 1.0 mL of modi-
fied BWW containing albumin.
After thawing, Prog% and Vit% were evalu-
ated, being the Prog% evaluated before and after re-
moval of cryoprotective diluent. After diluent re-
moval, the Prog% was evaluated at different time in-
tervals (zero, 3, and 24 h).
Statistical Analysis
The criterion of data normality was evalu-
ated through the Kolmogorov-Smirnov test. Because
the variables do not assume a normal distribution, the
evaluation of differences of Prog% and Vit%, between
pre-freezing and post-thawing, and between pre and
post cryoprotector removal (Prog%), was accom-
plished through the non-parametric test of Wilcoxon.
Differences between samples frozen through manual
and automated technique in relation to Prog% and
Vit% values were evaluated through the Friedman test.
The data is expressed as median and 25% and 75%
percentiles. Values of p ≤ 0.05 were considered as
statistically significant. Statistical analysis was ac-
complished through StatSoft program, Tulsa, OK,
USA.
RESULTS
The percentage of spermatozoa showing pro-
gressive motility (Prog%) and the percentage of live
spermatozoa (Vit%), before and after cryopreservation
by using the vapor and  automated techniques, are ex-
pressed in Table-1. There was significant reduction of
Prog% and Vit% from before freezing to after thaw-
ing, for both groups, I and II (p < 0.001). Values of
Prog% and Vit% were not statistically different after
thawing, between groups I and II.
Post-thawing values of Prog%, before
cryoprotector removal, and at zero, 3 h, and 24 h af-
ter its removal, are expressed in Table-2. There was
no difference in Prog% for groups I and II before re-
moval of the cryoprotective diluent. It has been ob-
served, nevertheless, stronger Prog% reduction in
aliquots frozen through the automated technique af-
ter dilution and centrifugation for removal of the cryo-
protective diluent (p = 0.006). After cryoprotector
removal, the Prog% was not altered, in both groups,
during the first 3 hours of incubation, although being
superior in group I (p = 0.04). There was a signifi-
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Table 1 – Percentage of spermatozoa showing progressive motility (Prog%) and percentage of live spermatozoa (Vit%),
before and after cryopreservation by using vapor and automated techniques, in 15 samples of patients having
oligoasthenozoospermia.
Spermatic Parameters                          Prog% Median (25%-75%)    Vit % Median (25%-75%)
Pre-freezing
Post-thawing
   • Vapor
   •  Automated
Value of  P 1
Value of  P 2
1 Comparison of Prog% and Vit% values for before freezing and after thawing; 2 comparison of post-thawing values of Prog% and
Vit% among aliquots frozen through the vapor and automated techniques.
42.0 (35.0 - 48.0)
 8.0 (3.0 - 24.0)
10.0 (2,0 - 28.0)
< 0.001
  0.84
89.0 (82.0 - 92.0)
46.5 (39.5 - 61.5)
58.0 (35.0 - 71.5)
 0.007
0.34
cant fall in Prog% after 24 hours of incubation, for
both groups (p < 0.01).
DISCUSSION
In spite of using modern protocols for
cryopreservation of human semen, sperm survival
after defrosting remains unsatisfactory, and pregnancy
rates are inferior to those obtained with fresh semen
(7). Various studies have shown that the freezing  and
thawing process of human semen leads to the decrease
of sperm motility (8), alterations in the pattern of
penetration in the cervical mucus, decrease of pen-
etration in hamster oocytes (9), alterations in the
acrosomal structure and in the plasmatic membrane,
besides the decrease in the activity of acrosomal pro-
tease (acrosin) (10). The main factors involved in the
physiopathology of these events are the osmotic ef-
fects of the freezing  and thawing process over the
plasmatic membrane of spermatozoa, leading to al-
terations of permeability and cellular death (11); and
the sub-lethal damage that results from a combina-
tion of factors, including: cellular dehydration and
re-hydration, besides alterations in the cellular bio-
chemistry and physiology (decrease of enzymatic
activity, activation of lipidic peroxidation cascade,
with consequent generation of reactive species of
oxygen and oxidative damage) (12).
The fertility potential of cryopreserved semen
depends, mainly on the initial quality of the sample,
on the cryoprotector used, and on the freezing  tech-
nique. Since the decade of 60’s, cryopreservation of
human semen is been routinely accomplished through
the liquid nitrogen vapor technique, by using glyc-
erol as cryoprotector (13). The best survival of hu-
man spermatozoa is obtained when: 1) the cooling
velocity of room temperature up to 4/5°C is of 0.5
to 1.0°C/minute; 2) the freezing velocity of the fu-
sion point up to -80°C is around 10ºC/minute (14),
i.e., fast enough to minimize dehydration, but not
so quick to cause the formation of intracellular ice.
Both techniques employed in this study follow these
principles, being such velocity just estimated when
using the vapor technique, while with the automated
technique it is possible to exactly program the freez-
ing velocities for each process phase. Yin & Seibel
(15) checked the temperatures inside and outside of
the semen samples frozen through the vapor tech-
nique, and have verified that after 10 minutes inside
the vapor, the temperature of the sample reached –
80°C, which is compatible with  a mean freezing ve-
locity of –10ºC/minute. Nevertheless, these authors
have observed a variation of ±6°C/minute in the dif-
ferent points of the curve, and discrepancy of up to
30°C between the temperatures of vapor and sample.
As the control of temperature by using the
biologic freezer is more exact, many studies have been
accomplished in the intention of comparing both tech-
niques. Although some have shown that the automated
freezing preserves the quality of human semen better
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Table 2 - Post-thawing values of the percentage of spermatozoa showing progressive motility (Prog%), before dilution
and centrifugation for removal of cryoprotector, and for different incubation periods (zero, 3 h, and 24 h) after its
removal, in 15 samples of patients having oligoasthenozoospermia.
Removal of Cryoprotector Vapor        Automated       Value of P 1
Before
After
  zero h
       3 h
     24 h
2 Value of P a X b
2 Value of P  b X c
2 Value of P  b or c X d
8.0 (3.0-24.0) a
9.0 (1.0-16.0) b
9.0 (2.0-15.0) c
1.0 (0.0-5.0) d
0.22
0.69
  0.003
10.0 (2.0-28.0) a
5.0 (1.0-17.0) b
5.0 (1.0-10.0) c
0.0 (0.0-3.0) d
  0.006
0.06
  0.002
0.84
0.13
0.04
0.62
1 Comparison of Prog% values among aliquots frozen through the vapor and automated techniques; 2 comparison of Prog% values
before removal of cryoprotector, and in different incubation periods (zero, 3 h, and 24 h) after its removal.
than the vapor technique (16,17), others do not con-
firm such benefit (18,19).
Infertility is one of the sequels of cancer treat-
ment. In approximately 50% of individuals with can-
cer, the seminal quality is already decreased before the
beginning of the treatment. Oligoasthenozoospermia
is observed in 17-77% of testicle cancer patients and
in 2/3 of Hodgkin disease patients (20). Many men in
reproductive age having cancer are directed to
cryopreservation of semen before beginning chemo-
therapy and/or radiotherapy. In this study, we have used
samples of oligoasthenozoospermic semen, for they
are the most frequently obtained from individuals that
have cancer and are directed to the semen bank. We
have not observed differences between the techniques
in what concerns spermatic motility and vitality. Ragni
et al. (21), on the other hand, have compared the 2
freezing techniques in semen samples from men that
had testicle cancer and Hodgkin disease, and have
verified better sperm motility with the use of auto-
mated freezing. Progressive sperm motility is one of
the crucial parameters for low complexity assisted
reproduction techniques to be successful, as intra-uter-
ine insemination (22). Besides that, motility is ac-
cepted as an indicator of efficacy in the process of
freezing and thawing (10).
When we compare cryo-efficiency, other
factors besides those mentioned above should be
taken into consideration, like cost, time, and sim-
plicity of method execution, besides practical im-
plications. The automated freezer is expensive and
consumes 3 to 5 times more liquid nitrogen than the
vapor technique. Although the execution time of the
method is similar between the techniques, the auto-
mated freezing is less laborious, as the biologic freezer
needs to be constantly monitored. In a practical point
of view, freezing through the vapor technique is more
convenient, because it allows the freezing of patients’
semen at any moment in the day, being possible also
to maintain the samples in the vapor at –80°C during
the night, without harming the final quality of the
process. Besides that, any difference in the final qual-
ity of the frozen semen should be interpreted with
caution, because for semen samples with very low
initial quality ( < 5.0x106 motile spermatozoa), intra-
uterine insemination will be rarely viable to obtain
pregnancy, being necessary to use in vitro fertiliza-
tion associated to the intracytoplasmic sperm injec-
tion, whose chance of success does not seam to di-
minish even in cases in which very few motile sper-
matozoa are present (20).
In the majority of studies, sperm quality after
freezing and thawing using a variety of techniques is
evaluated immediately after thawing. Nevertheless, the
cryoprotective diluent, which has toxic effects over
the oocytes, should be removed in order to prepare the
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spermatozoa for intra-uterine insemination or in vitro
fertilization (23). Removal of cryoprotector, which is
accomplished through the dilution with culture medium
and centrifugation, causes osmotic shock and even
diminishes the final quality of the cryopreserved
semen. In this study, the removal of the cryoprotective
diluent had a negative impact over the progressive
motility of spermatozoa cryopreserved through the
automated technique. This harmful effect did not occur
with the thawing through the vapor technique.
Explanation for this finding is not clear, but it can be
due to the thawing technique that has been employed.
In both groups, the spermatozoa were thawed at room
temperature for 5 minutes, with subsequent incubation
at 37°C. Progressive motility immediately after
thawing was similar between groups, but has
diminished in 50% after dilution and centrifugation
with the automated technique. Other studies have
shown that for freezing through the automated
technique, the best sperm recovery is obtained through
slow thawing, i.e., by keeping the samples under 22°C
for at least 10 minutes (16,18). Taylor et al. (16) and
Verheyen et al. (18) have also observed significant
reduction in the sperm motility after dilution and
centrifugation for cryoprotector removal, which was,
nevertheless, of the same magnitude for the manual
and automated techniques. Nevertheless, the studies
are not comparable, because the thawing protocol was
different, and the authors assessed semen samples with
high initial quality, while we have assessed samples
with low initial quality.
In this study, both cryopreservation
techniques allowed for progressive motility after
thawing and removal of cryoprotector to be kept
unaltered during the first 3 hours of incubation, being
drastically diminished after 24 hours. Such fact has
a practical importance, because the longevity of
spermatozoa submitted to the freezing and thawing
process is short, and the use of them in assisted
reproduction procedures should be adequately
synchronized.
CONCLUSIONS
Vapor and automated techniques are similar
for oligozoospermic samples in terms of recovery of
spermatozoa with progressive motility after thawing.
After thawing, the longevity of spermatozoa is short,
and they should be preferably used within the first 3
hours after removal of cryoprotector. The effects of
dilution and centrifugation for the removal of the
cryoprotector had negative impact only in samples
frozen through the automated technique, and such
difference can be related to the thawing speed, which
will be assessed in a coming study.
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EDITORIAL COMMENT
The technique of spermatozoa freezing should
be very encouraged in cases of cancer, before beginning
treatment, regardless of sample quality. The new
techniques of assisted reproduction, especially the
intracytoplasmic sperm injection  (ICSI) might allow
for a posterior pregnancy, even by using bad quality
spermatozoa previously frozen, or with low recovery
after thawing.
In this work, the observation that the process
of freezing by using programmed freezer did not show
any advantage over traditional freezing by using
nitrogen vapor, is of a great value, for it diminishes
the cost of treatment, well known as being high for
the couple.
Dr. Paulo Neves
 Laboratory of Human Reproduction
State University of Campinas, Unicamp
Campinas, São Paulo, Brazil
